| Literature DB >> 16838038 |
Abstract
Serum parathyroid hormone (PTH) is a recognized marker of bone remodeling in patients with renal osteodystrophy. However, identification of N-terminal truncated PTH fragments and a new form of PTH that interfere with second-generation PTH assays may be responsible for the great variability of PTH values and the difficulties of implementing the recommendations of the National Kidney Foundation/Kidney Disease Outcomes Quality Initiative.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16838038 DOI： 10.1038/sj.ki.5001658
Source DB: PubMed Journal: Kidney Int ISSN： 0085-2538 Impact factor: 10.612